We have used transient kinetics, nanosecond time-resolved fluorescence resonance energy transfer (FRET), and kinetics simulations to resolve a structural transition in the Dictyostelium myosin II relay helix during the actin-activated power stroke. The relay helix plays a critical role in force generation in myosin, coupling biochemical changes in the ATPase site with the force-transducing rotation of the myosin light-chain domain. Previous research in the absence of actin showed that ATP binding to myosin induces a dynamic equilibrium between a bent prepower stroke state of the relay helix and a straight postpower stroke state, which dominates in the absence of ATP or when ADP is bound. We now ask whether actin binding reverses this transition and if so, how this reversal is coordinated with actin-activated phosphate release. We labeled a Cys-lite Dictyostelium myosin II motor domain with donor and acceptor probes at two engineered Cys residues designed to detect relay helix bending. We then performed transient timeresolved FRET following stopped-flow mixing of actin with labeled myosin, preincubated with ATP. We determined the kinetics of actin-activated phosphate release, using fluorescent phosphatebinding protein. The results show that actin binding to the myosin.ADP.P complex straightens the relay helix before phosphate dissociation. This actin-activated relay helix straightening is reversible, but phosphate irreversibly dissociates from the postpower stroke state, preventing reversal of the power stroke. Thus, relay helix straightening gates phosphate dissociation, whereas phosphate dissociation provides the thermodynamic driving force underlying force production.
We have used transient kinetics, nanosecond time-resolved fluorescence resonance energy transfer (FRET), and kinetics simulations to resolve a structural transition in the Dictyostelium myosin II relay helix during the actin-activated power stroke. The relay helix plays a critical role in force generation in myosin, coupling biochemical changes in the ATPase site with the force-transducing rotation of the myosin light-chain domain. Previous research in the absence of actin showed that ATP binding to myosin induces a dynamic equilibrium between a bent prepower stroke state of the relay helix and a straight postpower stroke state, which dominates in the absence of ATP or when ADP is bound. We now ask whether actin binding reverses this transition and if so, how this reversal is coordinated with actin-activated phosphate release. We labeled a Cys-lite Dictyostelium myosin II motor domain with donor and acceptor probes at two engineered Cys residues designed to detect relay helix bending. We then performed transient timeresolved FRET following stopped-flow mixing of actin with labeled myosin, preincubated with ATP. We determined the kinetics of actin-activated phosphate release, using fluorescent phosphatebinding protein. The results show that actin binding to the myosin.ADP.P complex straightens the relay helix before phosphate dissociation. This actin-activated relay helix straightening is reversible, but phosphate irreversibly dissociates from the postpower stroke state, preventing reversal of the power stroke. Thus, relay helix straightening gates phosphate dissociation, whereas phosphate dissociation provides the thermodynamic driving force underlying force production.
muscle | time-resolved FRET | structural kinetics T he myosin ATPase family uses the free energy of ATP hydrolysis to power a cycle of changes in myosin structure. These changes perform mechanical work, essential for motility in all eukaryotic cells. The efficient production of work by myosins is controlled by nucleotide and actin binding in coordination with a reversible rotation of the myosin light-chain domain, hypothesized to act as a force transducing "lever arm" (1) (2) (3) . The myosin relay helix is crucial for this coordination (1, 4, 5) .
The structure of the relay helix is coupled to nucleotide binding and to the orientation of the light-chain domain. The relay helix is straight when myosin is crystallized with bound nonhydrolyzed ATP, prehydrolysis ATP analogs, or ADP or in the absence of nucleotide (abbreviated apo) and bent when crystallized with bound posthydrolysis ATP analogs (Fig. 1A , nucleotide free, IFMV, and ADP.Vanadate bound, 1VOM, crystal structures shown) (3, (6) (7) (8) (9) . There is no crystal structure of myosin bound to actin, but the relay helix is straight in a myosin-V crystal structure that is hypothesized to exhibit features of an actin-bound state (10) and also in a 0.8-nm resolution cryo-electron microscopy model of actin-bound myosin (11) . In each of these studies, the orientation of the light-chain domain mirrors the structural state of the helix-when the helix is bent, the light-chain domain is in a prepower-stroke orientation, and when the helix is straight, the light-chain domain is in a postpower-stroke orientation.
The structural dynamics of the relay helix are coupled to nucleotide binding in solution. ATP binding initiates a tryptophan fluorescence change in the relay loop, C-terminal to the helix. This change is hypothesized to coincide with relay helix bending and with the myosin recovery stroke, essential for force production (12) (13) (14) (15) . The forward and reverse rate constants for this transition are >100 s −1 before ATP hydrolysis and <1 s −1 after hydrolysis (16, 17) . In the absence of actin, the slow, post hydrolysis reversal of the recovery stroke precedes phosphate dissociation, the rate-limiting biochemical step (17) . Because actin binding increases the myosin phosphate release rate, actin should accelerate this transition and straighten the relay helix, coinciding with the initiation of the power stroke (17, 18) . A previous study reported tryptophan fluorescence transients near the relay helix during actin-binding transitions in the presence of ATP (19), but that study was complicated by substantial tryptophan fluorescence and light scattering from actin (16) .
We set out to test these hypotheses more directly, using spectroscopic distance measurements that detect relay helix structure. EPR and FRET were used to measure helix bending in the absence of actin (20) . This study showed that the relay helix exists in dynamic equilibrium between a straight (M*) state that predominates in the presence of ADP or no nucleotide and a bent (M**) state induced by analogs of ATP or ADP.P. Another study introduced an approach called transient time-resolved FRET, (TR) 2 FRET, detecting nanosecond-resolved FRET, simultaneously sensitive to both the M* and the M** structural states of the relay helix, during the millisecond-resolved transient phase following the stopped-flow mixing of ATP with labeled myosin (21). This approach allowed us to resolve the mole fractions of the M* and M** structural states of the relay helix directly and simultaneously during the transient myosin recovery stroke, showing that ATP binding stabilizes the M** state before hydrolysis and that both structural states remain populated throughout the transient.
The present study extends this approach to include actin, to probe the pivotal actin-activated myosin power stroke. We first use both TR-FRET and EPR-based distance measurements to resolve the M* and M** structural states in the presence of actin under steady-state biochemical conditions. We then mix FRET-labeled myosin with ATP and then perform (TR) 2 FRET after rapid mixing with excess actin. In parallel experiments, we measure phosphate release kinetics, using a fluorescent phosphate-binding protein. Thus, we detect the power stroke structural kinetics in real time and determine the temporal correlation with phosphate release, to answer one of the most fundamental questions about actomyosin force generation: How is the power stroke coordinated with actin-activated dissociation of hydrolyzed phosphate?
Results
Resolution of the Straight and Bent Structural States of the Relay Helix in Biochemical Steady States by TR-FRET and DEER. Previous work from this laboratory showed that the relay helix is partitioned between straight M* and bent M** structural states (Fig. 1A , green and red helices, respectively) that can be detected by both TR-FRET and time-resolved EPR (DEER) (20, 21). The M* state predominates in the absence of nucleotide or when ADP is bound to myosin, whereas in the presence of ATP, the helix is in dynamic equilibrium between the M* and M** states. These studies were performed in the absence of actin. We now use a similar strategy to test the hypothesis that actin stabilizes the M* state, straightening the relay helix during the weakto-strong actin-binding transition in the presence of ATP, i.e., the power stroke.
We began by measuring the effect of actin on relay helix structure under equilibrium or steady-state biochemical conditions (Fig. 1) . TR-FRET was performed, measuring the distance between AEDANS (donor probe) and DABCYL (acceptor probe) attached at engineered cysteine labeling sites (residues 515C and 498C) in an expressed Dictyostelium myosin 2 catalytic domain construct, termed S1dC, in the presence of ATP or actin. Probes attached at these sites detect relay helix bending as an increase in FRET (20, 21) via a decrease in AEDANS lifetime. We equilibrated donor-only or FRET-labeled myosin with ATP or actin and then acquired time-resolved fluorescence waveforms (Methods). The measured waveforms in the absence of nucleotide and actin (apo) were nearly identical to those in the presence of actin (rigor). In the presence of excess ATP, the nanosecond decay rate increased (Fig. 1B) , clearly indicating increased FRET and decreased interprobe distance (Eq. S5), consistent with relay helix bending (20).
We analyzed the TR-FRET waveforms (SI Methods) by fitting the combined set of donor-only and FRET-labeled samples to a global time-resolved FRET model in which each structural state corresponds to a Gaussian distribution of interprobe distances (Fig. 1C , fits in Fig. 1B ). As reported previously (20), two structural states indicated by a short interprobe distance distribution (2.6 ± 0.5 nm) and a longer more disordered (3.1 ± 1.7 nm) distance distribution were resolved in the presence of ATP (Fig. 1C . Our previous work showed that the longer distance corresponds to the M* structural state where the relay helix is straight, whereas the shorter distance corresponds to the M** structural state where the relay helix is bent (20, 21). In the apo and rigor samples, the mole fraction of the M* state is 1.0; i.e., M** is not detected. Addition of ATP shifts the distribution, decreasing M* to 0.59 and increasing M** to 0.41 (Fig. 1C, total distribution, magenta) . The time-resolved fluorescence (Fig. S1 ). anisotropy (Fig. S2) , and accessibility ( Fig. S2 ) of myosin labeled with the AEDANS donor alone were not affected by ATP or actin, indicating that the nucleotide-and actin-dependent changes in the M*/M** equilibrium reflect changes in energy transfer, not changes in the fluorescence or dynamics of the AEDANS donor.
We used time-resolved EPR ( Fig. 1 D and E) to measure the distance between spin labels attached at these same sites in the absence or presence or either actin or ATP analogs. We detected a single distance in the apo samples (Fig. 1E) . Binding of the ATP analogs ADP.Aluminum.Fluoride (ADP.AlF) or ADP.Vanadate (ADP.V), induced a second shorter distance (Fig. 1E) . Samples containing actin exhibited a single distance distribution that was similar to that of the apo state (Fig. 1E) . Together, the TR-FRET and DEER experiments show that the relay helix is partially bent in the presence of ATP without actin and completely straight when myosin is bound to actin in rigor.
Direct Detection of the Actin-Activated Power Stroke by Transient Time-Resolved FRET. We determined the structural kinetics of the M* and M** states during the weak-to-strong actin binding transition in the presence of ATP by detecting (TR) 2 FRET (Fig. 2) . This experiment was performed using a single-mix stopped-flow device capable of acquiring nanosecond-resolved TR-FRET waveforms every 0.1 ms during a biochemical rapid-mixing experiment (21, 22). To overcome the single-mix limitations of the stopped-flow accessory, we performed these experiments with a 1:17 mixture of myosin with ATP in syringe A and actin with 2 mM ADP in syringe B. When bound to actin, the myosin used in this study binds ADP with a 14-μM K d (Fig. S3) (23) . Thus, the added ADP competes with the residual ATP and traps the rigor complex after a single ATP turnover. Under these conditions, actin binding to myosin in the presence of ATP caused (Fig. 2 A and B) .
We globally fitted a set of (TR) 2 FRET waveforms corresponding to donor-only and FRET-labeled myosin, in the presence of ATP and in the presence and absence of actin, with the M*/M** structural model described in Fig. 1 . This allowed us to simultaneously define the two structural states, M* and M** (Fig. 1C) , and the time-dependent mole fractions of these states during the ATP-induced recovery stroke (Fig. 2C) and weak-to-strong actin-binding transient (power stroke, Fig. 2D ). This two-state model was sufficient to describe the waveforms through the entire course of the transient over all actin concentrations examined; i.e., adding an additional structural state to the model did not decrease the fit χ 2 . Thus, M* and M** are the only two structural states resolved by (TR) 2 FRET in our experiments. ATP binding to myosin caused the mole fraction of the M* state to decrease (Fig. 2C) , and actin binding to myosin in the presence of ATP reversed this transition (Fig. 2D) . The actinactivated M* and M** transients exhibited three distinct kinetics components ( Fig. 2D and Tables 1 and 2 ): a rapid-equilibrium phase (Fig. 2D, phase 1 ) that was largely complete in the first 10 ms, an actin-dependent phase (Fig. 2D , phase 2) that increased from 50 s −1 at 10 μM actin to more than 100 s −1 at 40 μM actin ( Fig. 3 A and B) , and a slow phase (Fig. 2D, phase 3 ) that was insensitive to increasing actin (9.9 ± 0.5 s
−1
). The mole fraction of M* and M** states did not change when we mixed FRET-labeled myosin with actin in the absence of ATP (Fig. 2E) or when we mixed FRET-labeled myosin bound to actin with 1 mM ADP (Fig. 2E) , indicating that the M**→M* transition observed in (Fig. 2D) reflects the actin-dependent reversal of the recovery stroke and not structural changes associated with actin or ADP binding.
These results are supported by control experiments performed using a conventional stopped-flow device capable of sequential mixing but not TR-FRET (Fig. S4) . These controls confirmed that actin binding to myosin increases the average distance between FRET probes (Fig. S4) , whereas neither actin nor ADP affects FRET in the absence of ATP. Furthermore, the amplitude of the total FRET change increased with increasing aging time (0.05-1 s) between the first mix with ATP and the second mix with actin (Fig.  S4 ). The amplitude of the FRET change was maximal when the myosin/ATP mixture reached biochemical steady state, as indicated by experiments detecting ATP binding and hydrolysis via tryptophan fluorescence (Fig. S5) and by FRET following a single mix of myosin with 100 μM ATP (Fig. S4A) . Thus, the actindependent change in FRET is sensitive not only to ATP binding, but also to ATP hydrolysis, and reflects actin-induced straightening of the relay helix in the posthydrolysis myosin.ADP.P biochemical state. This control also shows that the (TR) 2 FRET experiments, performed under steady-state myosin/ATP conditions, exhibited the maximum actin-activated change in the M*/M** equilibrium.
Actin Straightens the Relay Helix Before Phosphate Release. ATP binding initiates the relay helix recovery stroke, increasing the mole fraction of the bent M** state (Figs. 1 and 2) (21). It has been proposed that phosphate dissociation following hydrolysis is coupled to helix straightening (4, 5, 17) . To test this hypothesis, we measured actin-activated phosphate release, using phosphatebinding protein labeled with 7-diethylamino-3-((((2-maleimidyl) ethyl)amino)carbonyl)coumarin (MDCC-PBP, described in SI Methods), mixing myosin (2.5 μM, postsecond mix) with ATP (1.6 μM, postsecond mix), aging the sample for 1 s to allow preand posthydrolysis states to reach steady state, and then mixing the steady-state reaction with varied concentrations of actin. The resulting increase in fluorescence of MDCC-PBP was biphasic (Fig.  3C) . The fast phase reflects the actin-activated phosphate release burst from the posthydrolysis myosin.ADP.P biochemical state, whereas the slow phase reflects equilibration of prehydrolysis states through hydrolysis as well as slow removal of free phosphate by the phosphate mop added to scavenge micromolar contaminating phosphate from the stopped-flow instrument and buffers (24-26). The observed rate constant for the phosphate release burst increased with increasing actin (Fig. 3 C and D and Tables 1  and 2 ) and was always slower than phase 1 and phase 2 of relay helix straightening and faster than phase 3 of helix straightening. Phosphate release was faster than actin-activated ADP dissociation measured during single-nucleotide turnover ( Fig. 3 C and F and Tables 1 and 2 ), which increased hyperbolically with K 0.5 = 13.0 ± 1.2 μM and maximum k obs = 6.5 ± 0.31 s
, comparable to the steady-state ATPase V max (9.4 ± 0.8 s
, Fig. S6 ). The difference in the actin dependence of helix straightening, phosphate release, and nucleotide turnover indicates that actin binding initiates an isomerization in the relay helix that precedes dissociation of phosphate and dissociation of ADP. This hypothesis is discussed below.
Discussion
Powerstroke Precedes Phosphate Release. After ATP binding initiates the recovery stroke and hydrolysis (SI Methods, Scheme 1a), phosphate dissociates through either the futile power stroke (SI Methods, Scheme 1b) or the actin-activated power stroke (SI Methods, Scheme 2a or SI Methods, Scheme 2b) pathway. In the absence of actin, the forward rate constant for the futile power stroke step (SI Methods, Scheme 1b, step K 1b ) is slow (k +1b = 0.05 s ), limiting the rate of phosphate release (17) and ATPase cycling. The coordination of phosphate release and the power stroke during actin activation is under debate (1, 4) . Does the power stroke precede phosphate release (SI Methods, Scheme 2a) (4) or does phosphate release precede the power stroke (SI Methods, Scheme 2b) (1)? Our (TR) 2 FRET experiments provide a clear answer.
Solutions to the differential equations that describe SI Methods, Scheme 2a and SI Methods, Scheme 2b show that in SI Methods, Scheme 2a, the value of k obs for the power stroke is always equal to or greater than that of phosphate release, whereas the opposite is true in SI Methods, Scheme 2b. (TR) 2 FRET shows that both phase 1 (k max > 500 s −1 ) and phase 2 (k max > 200 s −1 ) of the actinactivated M**→M* transition ( Fig. 2C and Tables 1 and 2 ) are substantially faster than phosphate release (k max = 37 s
−1
). This result is consistent with SI Methods, Scheme 2a but not with SI Methods, Scheme 2b, so we conclude that the M**→M* transition (relay helix straightening, which we associate with the power stroke) precedes phosphate release.
M*/M** Equilibrium Is Coupled to Actin Binding and Hydrolysis. To determine whether the above conclusion, that relay helix straightening gates phosphate release, is consistent with the total actomyosin ATPase cycle, we used numerical integration performed with the KinTek Explorer global analysis software (27) (described in SI Methods) to model the structural kinetics of an expanded actomyosin ATPase scheme (Fig. 4 , Scheme 3). Our model contains three myosin structural states (M, M*, and M**, analogous to the M, M*, and M † states described elsewhere) (17), each of which binds nucleotide (ATP, ADP.P, ADP, abbreviated T, D.P, and D, respectively) and actin (abbreviated A in Scheme 3). In our scheme, M and M* reflect straight (postpower stroke) structural states of the helix, with only the M state capable of exchanging free and bound nucleotide and the M* state exhibiting increased nucleotide binding affinity (17) . M** reflects the bent (prepower stroke) structural state of the helix. We globally fitted the rate constants in Scheme 3 to data from stopped-flow experiments measuring actin and nucleotide binding, actin-activated Table 2 . Summary of rate constants for actin-activated structural and biochemical transitions: simulations
SEs were calculated from the fitting program. (Fig. 4) show that the actin-binding affinity, K d(actin) , is coupled to the hydrolysis and structural state of the myosin species. The K d(actin) is 0.5 μM for M*T, 7 μM for M**T, and 91 μM for M**D.P. The simulations were not directly sensitive to the M*D.P state, because it is not significantly populated under the conditions of our experiments. However, microscopic reversibility of states thermodynamically coupled to M*D.P indicate that it binds actin with a K d of 9 μM. These results are consistent with previous observations that ATP hydrolysis decreases actin-binding affinity, from 1 μM to >20 μM (17, 26) .
Actin binding increased the M*/M** equilibrium constant from 4.5 in the M*T↔M**T transition to 15 in the A.M*T↔A. M**T transition. The M*/M** equilibrium of posthydrolysis states is also shifted by actin from 0.3 in the M*D.P↔M**D.P transition (17) to 3.5 in the A.M*D.P↔A.M**D.P transition, similar to the estimated equilibrium constant determined by relay loop tryptophan fluorescence in the presence of actin (19). Thus, whereas the A.M*D.P/A.M**D.P equilibrium controls the power stroke, the A.M*T/A.M**T equilibrium inhibits actinassociated hydrolysis from A.M**T while also preventing the recovery stroke before actomyosin dissociation.
Kinetics simulations provided an explanation for the three distinct phases in the actin-activated M**→M* transient (Fig. 2C) . Phase 1 is due to the reversal of the recovery stroke following rapid equilibrium binding of M*T to actin with a K d of 0.5 μM (Fig. 4B) . Depletion of M*T by actin binding disrupts the M*T/ M**T equilibrium, so M**T is rapidly converted to M*T (Fig. 4 B and C, phase 1). Phase 2 reflects the M**→M* transition following weaker binding of M**D.P to actin (K d = 91 μM) (Fig. 4B ). Phase 3 (Fig. 4B, 10 Tables 1 and 2 ). The dissociation of inorganic phosphate from the A.M**D.P state converts myosin into the strong-binding A.M*D state with 38-nM actin-binding affinity. We found that ADP binding does not alter the structure of the relay helix (Fig. 2) . Thus, the A.M*D/ A.M**D equilibrium is strongly poised toward the M* state. As a result, once phosphate dissociates, the myosin is trapped in a postpower-stroke state until ATP rebinding weakens the actomyosin interaction and lowers the free energy for the M*↔M** transition.
Conclusions
We have used (TR) 2 FRET to directly detect the key structural change within the myosin catalytic domain that defines the forcegenerating power stroke, actin-activated straightening of the relay helix. Our results show that actin straightens the relay helix in the early stages of the weak-to-strong actin-binding transition before phosphate release. We find that this straightening gates phosphate dissociation from myosin. The time-resolved measurements allowed direct and quantitative measurement of the mole fraction of bent and straight relay helix structural states and thus of the equilibrium constants for the critical actin-activated helix straightening transition. These results provide direct and vivid insight into one of the most enigmatic aspects of myosin enzymology, the coordination of actin-activated phosphate release and the myosin power stroke. It will be interesting in the Fig. S8 obtained by global kinetics fits to experimental data (representative data and fits in Fig. S7 ). Simulation conditions were myosin (6.5 μM) and ATP (50 μM) with saturating actin (1,000 μM) and ADP added as in Fig. 2 . Shown are total M* states, AM*T, AM**DP, AM*DP, and free phosphate, P. (C ) Predominant species from B plotted on a linear scale.
future to determine how force across the actomyosin cross bridge affects this coordination and how mutations that alter phosphate release affect the structural kinetics of the relay helix.
Methods
Protein Expression, Purification, and Labeling. All experiments in this study used a Cys-lite S1dC construct engineered for site-specific labeling by the introduction of reactive cysteine residues at positions 498 and 515. The design, expression, purification, and labeling (with EPR or FRET probes) of this construct are described in our previous reports (20, 21). Myosin expression and purification were carried out as described in these reports, with slight modifications described in SI Methods. Following this procedure, the labeled S1dC constructs retained actin-activated ATPase activity for 3 d on ice without freezing. All experiments were performed during this time. Actin was purified from rabbit skeletal muscle by acetone extraction (29) and then stabilized with stochiometric excess of phalloidin (Sigma Aldrich) followed by 24 h dialysis (three buffer changes) into nucleotide-free reaction buffer (specific for each experiment).
Steady-State ATPase Activity. We measured actin-activated MgATPase activity, using an NADH-coupled assay (25). ATPase reactions contained labeled or nonlabeled S1dC 515.498 constructs; varied concentrations of nucleotidefree, phalloidin-stabilized actin, 20 mM Hepes, pH 7.5, and 2 mM MgCl 2 ; and were initiated by the addition of 1mM MgATP. The reaction cuvette was maintained at 23°C while we monitored the absorbance at 340 nm for 2 min. V max and K ATPase of the nonlabeled and labeled proteins are nearly identical (Fig. S6) . . The resulting protein was largely free of contaminants and degradation products, as determined by Coomassie staining of SDS/PAGE gels (Fig. S6) . After purification, the protein was labeled for 16 h overnight on ice with 0.9 mol IAEDANS (Invitrogen) per mole purified S1dC. IAEDANS labeling was quenched with the addition of 1 mM DTT. Samples were added to a Zeba desalting column (7 kDa molecular mass cutoff) equilibrated in labeling buffer without TCEP and allowed to equilibrate for 10 min before spinning to facilitate removal of DTTreacted AEDANS. The AEDANS samples were then labeled with 4 moles of Dabcyl(Plus)-maleimide (Anaspec) per mole of S1dC, in labeling buffer without TCEP. Free dye was removed by passing the labeled protein through a 10-mL fast-flow size-exclusion column (GE Health Sciences) equilibrated in labeling buffer followed by a Zeba desalting column equilibrated in experiment buffer. This extensive gel filtration was required to remove residual free dye.
Time-Resolved FRET Analysis. Time-resolved fluorescence (TRF) waveforms from donor and FRET-labeled myosin were analyzed globally according to Eqs. S1-S13. The measured time-resolved fluorescence waveform, I(t),
is a function of the nanosecond decay time, t, and is modeled as the convolution integral of the measured instrument response function, IRF(t), and the fluorescence decay model, F(t). The fluorescence decay model
is a linear combination of a donor-only fluorescence decay function, F D (t) and an energy transfer-affected donor fluorescence decay, F DA (t). The donor decay F D (t) is a sum of exponentials
with discrete lifetime species τ i and preexponential mole fractions A i . For the AEDANS donor three exponentials were required to fit the observed fluorescence (2). The energy transfer-affected donor decay function, F DA (t),
is a sum over two structural states with mole fractions X j , represented by FRET-affected donor fluorescence decays T j (t). The increase in the donor decay rate (inverse donor lifetime) due to FRET is given by the Förster equation
where
We modeled time-resolved (TR)-FRET assuming that each structural state j (Eq. S4) corresponds to a Gaussian distribution of interprobe distances, ρ j (R):
As with our previous work (2), R 0i is calculated according to Eq. S11 from the spectral overlap integral, J, the orientation-sensitive term κ 2 , the refractive index n, and the donor quantum yield Q Di (Eqs. S12-S14). 〈Q D 〉 was measured as 0.28 ± 0.01, by comparison with a quinine sulfate fluorescence standard in 50 mM H 2 SO 4 at 20°C according to Eq. S14 (2):
Together, the donor fluorescence (A i , τ i ) and distance terms (R j , σ j ) in our analysis were shared globally between all waveforms containing FRET-labeled samples. R j and σ j were allowed to vary to within ±90% of the average AEDANS/DABCYL R 0 (3.8 nm in this study). The distance-dependent terms R j (Eq. S9) and σ j (Eq. S10) define structural states M* (j = 1) and M** (j = 2) of the myosin relay helix. The mole fraction terms X* and X** were allowed to vary independently in each wave-form. Thus, changes in the X i terms reflect changes in the relative populations of the structural states (j) as the biochemical state is varied under equilibrium, steady-state, or transient conditions. We determined the number of donor lifetimes (i) and structural states (j) that are present in each sample by fitting a set of models with the number of donor lifetime states, i, increasing from 1 to 4, and the number of structural states, j, increasing from 1 to 3. For each model we test a distribution of energy transfer rates, with σ j allowed to vary, as well as discrete energy transfer rates where σ → 0. The final model (i max = 3, j max = 2, σ > 0) was determined by evaluating the dependence of the minimized χ 2 on the number of free parameters in the global model (1) (2) (3) (4) and by the resolution of the χ 2 error surface support plane. This model, determined independently from data in this study, is in excellent agreement with our previous work (1, 5) . Reported uncertainties in model parameters are SEs from the fit and are in agreement with the maximum χ 2 error tolerance of 1 SD from the χ 2 minimum (3).
TRF Anisotropy and Acrylamide Quenching Data Analysis. We analyzed time-resolved fluorescence anisotropy as described in our previous work (2), according to EqS. S15-S18. The fluorescence lifetime and anisotropy terms are fitted globally to the timeresolved fluorescence waveforms acquired with the emission polarizer set at 0°, 90°, and 54.7°. We varied the number of fluorescence lifetimes, τ i (Eqs. S15-S17), and rotational correlation times, τ Ri (Eq. S18), applied to each biochemical condition:
Fð54:78; tÞ =
Fð08; tÞ = Fð54:78; tÞ · ½1 + 2rðtÞ=3
[S16]
Fð908; tÞ = Fð54:78; tÞ · ½1 − 2rðtÞ=3
[S17] rðtÞ = r ∞ + r i expð−t=τ Ri Þ:
[S18]
As described previously, the AEDANS donor is best described by a three-exponential fluorescence decay (i = 3). A single-exponential anisotropy function was sufficient to describe the diffusion of each lifetime. We assumed that each of the AEDANS lifetimes experiences the same global motion and thus is described by the same anisotropy function. Fitting to independent anisotropy functions did not reveal differences in anisotropy between the three lifetime states. The total anisotropy, r 0 , was calculated according to Eq. S19:
We used the total anisotropy to calculate the probe depolarization factors, d
x P (Eq. S20), with the anisotropy of a ridged assembly of probes, r f, . of 0.4. We assumed that the Dabcyl acceptor, which is dark, exhibits the same anisotropy as the AEDANS donor. The maximum and minimum values of the orientationsensitive term κ 2 were calculated according to Eqs. S21 and S22 and the resulting maximum and minimum range for the average Ro according to Eq. S23 (Fig. S2) .
Acrylamide quenching was analyzed by globally fitting the timeresolved fluorescence decays from samples in the absence and presence of 50 mM acrylamide according to Eq. S24 with the AEDANS lifetime distribution, defined by the sum of lifetimes, τ i , with mole fractions, A i , quenched by the Stern-Volmer quenching constant, k q , which is proportional to the concentration of acrylamide, C (4):
Dipolar Electron-Electron Resonance Spectroscopy. Dipolar electron-electron resonance (DEER) signals were acquired at Q-band with an Elexsys E580 spectrometer (Bruker Biospin) equipped with the SuperQ-FT microwave bridge (Bruker Biospin) and Q-band resonator (EN 5107D2; Bruker Biospin), using a four-pulse DEER sequence (6) with a 12-ns Pi/two pulse and a 24-ns ELDOR pulse. The pump frequency was centered on the central resonance of the nitroxide spin label, and the observed frequency was set to the low-field resonance 65-70 MHz downfield. Temperature during the acquisition was set to 65 K. Myosin samples (50-75 μM) were flash-frozen in liquid nitrogen before DEER acquisition. DEER signals were analyzed as described in our previous work (1).
Transient Kinetics of Phosphate Release. We detected dissociation of inorganic phosphate from myosin using phosphate-binding protein (PBP) labeled with 7-diethylamino-3-((((2-maleimidyl)ethyl)amino) carbonyl)coumarin (MDCC-PBP) (7). Reagents for the expression or PBP were generously provided by Howard White Eastern Virginia Medical School, Norfolk VA) (8) . The purification of PBP was modified from refs. 7 and 8. Following low hypo-osmotic release of recombinant PBP from cultured Escherichia coli, PBP was precipitated at 4°C with the addition of ammonium sulfate to 60% saturation, stirred gently for 30 min, and then spun at 15,000 × g for 15 min. The resulting supernatants were precipitated by addition of ammonium sulfate to 90% saturation for 60 min at 4°C and then spun at 15,000 × g for 15 min. The pellets, containing purified PBP, were dialyzed into 10 mM Tris buffer, pH 7.6, and then purified by ion exchange as described in refs. 7 and 8. The dominant eluted peak contains PBP, which is subsequently labeled with MDCC (Invitrogen). Free dye was removed by ion exchange on fast-flow Q-Sepharose eluted in a NaCl gradient (0-200 mM). Activity of MDCC-labeled PBP was determined by stopped-flow mixing 200 nM labeled PBP with increasing concentrations of inorganic phosphate (7, 8) . The rate constants for phosphate binding were 5.6 × 10 8 M −1 ·s −1 whereas the dissociation rate constant was 146 s −1 and the phosphate-binding K d was 270 nM. For experiments measuring the kinetics of actin-activated phosphate dissociation, MDCC-PBP (20 μM) was included in all syringes, along with phosphate mop (7) (8) (9) , which is added to remove contaminating free phosphate present in buffers, samples, and the stopped-flow instrument.
Differential Equations. The time-dependent evolution of species in Scheme 1a, Scheme 1b, Scheme 2a, and Scheme 2b (Kinetics Schemes) are described by systems of differential equations. To determine how the relative magnitude of the rate constants for each system affects the flux of mass through the system, we assumed that ATP and actin are in excess and thus ATP and actin binding steps are pseudofirst order and phosphate release is irreversible. We then solved each system, using the DSolve function in Mathematica to obtain a general solution valid for all values of the rate constants of each scheme. The general solutions to each system were expressed as a lengthy sum of roots of an exponential function with the amplitude and time constant terms dependent on the relative magnitude of the forward and reverse rate constants in each scheme. We then used the general solution to calculate how the initial rate of change (as the reaction time t→0) and the average rate of change of the total M*, M**, and free phosphate species in each system depend on the relative magnitude of each of the rate constants in the system. The results from this analysis showed that for all rate constant values >0, the apparent rate of change of a given species will always be as great, or greater than, the following step.
Kinetics Schemes. Scheme 1a.
When the rate constants for Scheme 1a are as defined in Scheme 1b.
When the rate constants for Scheme 1a are as defined in Fig.  S8 with myosin.ADP.P at 1 μM, M p ½t → 1 − e −0:05pt and P½t → 1 − e −0:05pt .
Scheme 2a.
When the rate constants for Scheme 2a are as defined in Fig. S8 , with myosin.ADP.P and actin at 1 μM and 50 μM, M pp ½t → 1-0:62e −249pt − 0:5e −25pt and P½t → 1 + 0:14e −49pt − 1:13e −26pt .
Scheme 2b.
When the rate constants for Scheme 2a are as defined in Fig. S8 , with myosin.ADP.P and actin at 1 μM and 50 μM, M pp ½t → 0:75-0:30e −213pt − e −60pt and P½t → 0:25 − 1:29 e −213pt + e −60pt .
Kinetics Modeling. We used Kintech Explorer (10) to model biochemical flux through a general myosin structural kinetics scheme (Scheme 3, Fig. 4 , steps listed in Fig. S8 ). The scheme is based on the Lymn-Taylor myosin kinetics scheme (11) expanded to include three myosin structural states termed M, M*, and M**. The M-to-M* transition corresponds to an isomerization in nucleotide binding (12) . Experiments by others suggest that this isomerization involves interaction of the nucleotide binding loops (switch-1, switch-2, and the p-loop) with nucleotide and a coordinated Mg +2 ion (reviewed in ref. 13 ). The M-to-M* isomerization is not detected directly by our relay helix FRET probes (because the helix is straight in both M and M* and bent in M**) (1), but it is required to fit the transient changes in the M* and M** populations during the actinactivated power stroke and active ATPase cycling, as both are influenced by the kinetics of M*T and M**T binding to actin and by the AMT↔AM*T transition that occurs after ATP binding to actomyosin (Fig. 4) .
We fit the set of rate constants in Scheme 3 (Fig. 4 , listed in Fig.  S8 ) to data from experiments measuring the recovery stroke and power stroke via relay helix (TR) 2 FRET, myosin and myosin. ADP binding to actin via light scatter (9) , ADP binding to myosin via 2′-O-(N-methylanthraniloyl)-ADP (mant-ADP) fluorescence (9), ATP-stimulated actomyosin dissociation via light scatter (9) , ADP binding to actomyosin via direct competition between ADP and ATP binding detected via actomyosin light scatter (9), phosphate release detected by MDCC-phosphatebinding protein (7, 8) , and steady-state ATPase cycling detected by the NADH coupled assay (9) . Scheme 3 contains six closed thermodynamic cycles (cycles 1-6, Fig. S8 ). We included microscopic reversibility as a constraint in fitting the global dataset. To do this, we first fitted the dataset without maintaining microscopic reversibility. We then calculated the detailed balance ðβÞ of each cycle according to β = ∏ k n;forward kn;reverse , where k n;forward and k n;reverse are the successive forward and reverse rate constants around a cycle with n steps. For cycles with detailed balance β > 2 or β < 0:5, the remaining balance, 1=β, was used to calculate a correction factor α, with α = β 1=2n . The rate constants were then corrected according to k corrected;forward = 1 α *k n;forward and k corrected;reverse = α*k n;reverse . The ratios between the corrected forward and reverse rate constants for each step were then kept constant while we minimized the fit a second time. Following this procedure, we were able to close cycles 1, 2, and 6 with β ∼1.0. We closed cycles 4 and 5 by calculating the rate constants for phosphate binding to M*D+P and AM*D and by fixing the M**DP↔M*DP transition on the basis of values reported in the literature (12) . These assumptions did not affect the global fit as the futile power-stroke pathway (Scheme 1b) is slow compared with the remaining steps and poorly populated during actin-activated ATPase cycling. The detailed balance for the final fit is reported in Fig. S8 . The final detailed balances for cycles 2 and 3 were 0.1 and 0.2, respectively, suggesting that there may be additional steps associated with actin binding by M*T or M**T that are not directly detected in our model. Such steps could include structural changes in the nucleotide-or actin-binding interface that are not directly sensed by (TR) 2 FRET.
Actin Binding Decreases Energy Transfer Between Relay-Helix-Sensitive FRET Probes. For our initial studies, we used a conventional stoppedflow device to mix myosin (3.2 μM postsecond mix) labeled with AEDANS (donor only) or AEDANS and Dabcyl (FRET) with excess ATP (50 μM, postsecond mix) (Fig. S4A) . We aged this sample for 1 s and then mixed the resulting steady-state ensemble with excess actin in stopped flow (Fig. S4 B and C) . During the transient phase after mixing, we detected changes in FRET, and thus relay helix structure, by measuring steady-state fluorescence emission intensity (470 ± 10 nm). In this study, "steady-state" fluorescence or FRET indicates that the fluorescence signal is monitored during continuous steady excitation, as opposed to "time-resolved" FRET, in which the signal is acquired with subnanosecond resolution following a nanosecond excitation pulse. ATP binding to myosin decreased the fluorescence of the FRET-labeled myosin (Fig. S4A , k obs = 10 s −1 , pH 7.3, 50 mM KCl), indicating that the average energy transfer between FRET probes increased, and thus the distance between probes decreased, during the ATP-binding transient. This result is in agreement with our previous work (14) and with the kinetics of ATP binding measured by tryptophan fluorescence (Fig. S5) . The ATP-induced fluorescence decrease contrasts with an increase observed when we mixed FRET-labeled myosin with actin (20 μM) after premixing myosin with excess ATP as in Fig. S4A (Fig.  S4B) . Thus, actin reverses the ATP-driven structural change. The actin-activated increase in fluorescence observed in Fig. S4B was slow (red line, average relaxation rate = 0.4 s −1 ), reflecting repeated cycles of ATP hydrolysis as the labeled myosin consumes the excess ATP.
The actomyosin ADP-binding K d for the myosin construct used in these experiments is 14 μM (Fig. S3) , as determined by ATP binding to an equilibrated mixture of pyrene-actomyosin in the presence of ADP (15) . The increased ADP-binding affinity of the construct compared with that of the wild-type S1dC is the result of the cysteine substitutions, specifically the SH2 cysteine, S1dC residue C678 (15), and not the length of the construct as was shown for a shorter construct that was truncated at residue 754 (16) or labeling of the construct as indicated by the actin-activated ATPase activity (Fig. S6) , which is not affected by the attachment of fluorescence probes to the labeling sites. Under these conditions, including excess ADP (1 mM postsecond mix) in the actin syringe inhibits additional rounds of ATP turnover by stabilizing the strong-binding actomyosin.ADP state (9) .
The rate of the actin-activated FRET change increased (Fig.  S4C , average relaxation rate = 4.9 s
) when we added ADP to the actin syringe. Control experiments showed that fluorescence did not change when we mixed labeled myosin (3.2 μM) with actin (20 μM) in the absence of ATP (Fig.  S4D ) or in the presence of ATP (50 μM) with the addition of EDTA (5 mM, Fig. S4E ) to inhibit Mg-stabilized ATP binding and hydrolysis. Nor did the fluorescence change when we first mixed the myosin with ATP (50 μM) and then with excess ADP (1 mM) (Fig. S4F) . These controls indicate that the actin-activated structural transition that is detected by FRET (Fig. S4 B and C) requires ATP binding to myosin followed by actin binding and that the structure of the helix is similar in both the myosin and the actomyosin states with or without ADP bound in the myosin active site. The changes in FRET reflect a structural change in the labeled myosin, as the fluorescence of the donor (Fig. S4G) does not change following mixing donor only-labeled myosin (3.2 μM) in the presence of ATP (50 μM) with actin (20 μM) in the presence of ADP (1 mM) whereas the fluorescence of myosin labeled with donor and acceptor, prepared and analyzed in parallel, does (Fig. S4G) .
The total change in FRET, initiated by actin binding in the presence of ATP, was dependent on the aging time following mixing myosin with nucleotide, increasing with a time constant of 37 ms, which is equivalent to an apparent rate constant of 27 s −1 , consistent with the rate constant for ATP hydrolysis detected by tryptophan fluorescence under similar conditions (Fig. S5) . This indicates that the maximum actin-activated FRET is observed after the myosin ATP mixture reaches biochemical steady state, indicating that the change in FRET reflects binding of posthydrolysis myosin.ADP.P and potentially prehydrolysis states as well, as described in Discussion in the main text.
We verified that the FRET-labeled myosin binds (Fig. S9 A, C, and D) and dissociates (Fig. S9B) from actin under mixing conditions similar to those in Fig. S4 , by measuring light scatter during the mixing transients (9) . In these control experiments, light scatter increased when we mixed myosin + ATP followed by actin with ADP (Fig. S9A) , myosin + actin with ADP (Fig. S9C) , and myosin + ATP and then + actin in the presence of 5 mM EDTA; all indicate that myosin bound to actin. In contrast, light scatter decreased in samples where we mixed actomyosin (2 μM myosin and 20 μM actin) with ATP (200 μM, Fig. S9B ), indicating that ATP triggers dissociation of labeled myosin from actin.
Time-Resolved Anisotropy and Accessibility of the AEDANS Donor Do
Not Change with Actin or Nucleotide Binding. Figs. 1 and 2 show that actin binding to myosin in the presence of ATP increases the distance between the donor and acceptor FRET probes. However, FRET is also sensitive to the relative distribution of dipole orientations. These cannot be measured directly. Changes in probe fluorescence lifetime, accessibility, or anisotropy can indicate changes in probe orientation and in the case of anisotropy suggest limits on the maximum and minimum values that the orientationsensitive term κ 2 can take (4, 17, 18) . The fluorescence lifetime of the AEDANS-labeled myosin construct used in this study did not change when either ATP or actin bound to the myosin (Fig. S1 ), supporting the proposal that the donor probe is in a similar environment in all biochemical conditions examined.
We measured time-resolved fluorescence anisotropy of labeled myosin under equilibrium nucleotide free (apo)-, actin-, and MgATP-bound biochemical conditions. The polarized time-resolved fluorescence waveforms were analyzed as described in SI Methods. Each of the biochemical conditions was best fitted by a single exponential anisotropy function. The initial anisotropy, correlation time, and final anisotropy were all within the SE of the measurement (Fig. S2) , indicating that the dynamics of the AE-DANS donor are not sensitive to actin or ATP binding. Consistent with this, the three samples could be analyzed globally, assuming the same fluorescence lifetime, initial anisotropy, correlation time, and final anisotropy terms over all biochemical conditions.
We measured the time-resolved fluorescence accessibility to acrylamide quenching (4) of AEDANS-labeled myosin to determine whether ATP or actin binding changed the solvent accessibility of the AEDANS donor probe. All three biochemical conditions examined (apo, actin, and ATP) exhibited the same degree of quenching (Fig. S2 , quenching constant k = 0.25 ± 0.05). Thus, neither nucleotide binding nor actin binding affects the local solvent accessibility of the AEDANS probe attached at either site used in the FRET studies. This provides further support for the anisotropy measurements and is in agreement with the control experiments in Fig. S1 , which showed that the fluorescence of the AEDANS donor is not affected by actin binding or by MgATP binding in the presence of actin. . Hyperbolic fit to k obs vs.
[ATP] was used to determine the maximum rate of ATP-induced change in tryptophan fluorescence, which corresponds to the sum of the forward and reverse rate constants for hydrolysis or light scatter, which corresponds to the forward rate of the AMT→AM*T transition. 
